David van de Vijver
Erasmus Universiteit Rotterdam
H-index: 49
Europe-Netherlands
Top articles of David van de Vijver
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Impact of an HIV cure on the HIV epidemic among men who have sex with men in the Netherlands | 9TH INTERNATIONAL CONFERENCE ON INFECTIOUS DISEASE DYNAMICS | Alfredo De Bellis Franco Romero Gonzalez Kim Romijnders Maartje Dijkstra Ard van Sighem | 2024 |
Scenarios of future mpox outbreaks among men who have sex with men: a modelling study based on cross-sectional seroprevalence data from the Netherlands, 2022 | Eurosurveillance | Marc C Shamier Luca M Zaeck Hannelore M Götz Bruno Vieyra Babs E Verstrepen | 2024/4/25 |
Response to “On the risk of using raw regional data on new HIV infections in France” by Tassi et al. | Journal of the International AIDS Society | Haoyi Wang Jean‐Michel Molina Rosemary Dray‐Spira Axel J Schmidt Ford Hickson | 2024/1 |
Analytical treatment interruption: detection of an increase in the latent, inducible HIV-1 reservoir more than a decade after viral resuppression | medRxiv | Cynthia Lungu Tanvir Hossain Henrieke AB Prins Kathryn S Hensley Raquel Crespo | 2023 |
Predicted effects of the introduction of long-acting injectable cabotegravir pre-exposure prophylaxis in sub-Saharan Africa: a modelling study | The Lancet HIV | Jennifer Smith Loveleen Bansi-Matharu Valentina Cambiano Dobromir Dimitrov Anna Bershteyn | 2023/4/1 |
Epidemiological impact and cost-effectiveness of expanding formal PrEP provision to PrEP-eligible MSM expressing PrEP-intention in the Netherlands | medRxiv | Haoyi Wang Stephanie Popping David van de Vijver Kai J Jonas | 2023 |
The BAF complex inhibitor pyrimethamine reverses HIV-1 latency in people with HIV-1 on antiretroviral therapy | Science Advances | Henrieke AB Prins Raquel Crespo Cynthia Lungu Shringar Rao Letao Li | 2023/3/15 |
Population‐level impact of expanding PrEP coverage by offering long‐acting injectable PrEP to MSM in three high‐resource settings: a model comparison analysis | Journal of the International AIDS Society | Sarah E Stansfield Jesse Heitner Kate M Mitchell Carla M Doyle Rachael M Milwid | 2023/7 |
Characteristics and short-and long-term direct medical costs among adults with timely and delayed presentation for HIV care in the Netherlands | Plos one | Stephanie Popping Lisbeth Versteegh Brooke E Nichols David AMC van de Vijver Ard van Sighem | 2023/2/8 |
HIV transmission among acutely infected participants of a Dutch cohort study 2015–2021 is not associated with large, clustered outbreaks | AIDS | Henrieke AB Prins Casper Rokx Annelies Verbon Ard Van Sighem Godelieve J De Bree | 2023/2/1 |
Spatio‐temporal changes in pre‐exposure prophylaxis uptake among MSM in mainland France between 2016 and 2021: a Bayesian small area approach with MSM population estimation | Journal of the International AIDS Society | Haoyi Wang Jean‐Michel Molina Rosemary Dray‐Spira Axel J Schmidt Ford Hickson | 2023/5 |
Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study | Sarah Blach Norah A Terrault Frank Tacke Ivane Gamkrelidze Antonio Craxi | 2022/5/1 | |
The epidemiological impact and cost-effectiveness of key population-led PrEP delivery to prevent HIV among men who have sex with men in Thailand: A modelling study | Lancet Regional Health South East Asia | Lisbeth Versteegh Sorawit Amatavete Tanat Chinbunchorn Noppawith Thammasiha Shreoshee Mukherjee | 2022/10/29 |
Significant impact of coronavirus disease 2019 (COVID-19) on human immunodeficiency virus (HIV) care in hospitals affecting the first pillar of the HIV care continuum | Clinical Infectious Diseases | Kathryn S Hensley Carlijn CE Jordans Jeroen JA van Kampen Femke PN Mollema Elisabeth H Gisolf | 2022/2/1 |
Serum markers associated with disease severity in a Bosnian hemorrhagic fever with renal syndrome cohort | Viruses | Danny Noack Maja Travar Visnja Mrdjen Jolanda JC Voermans David van de Vijver | 2022/6/24 |
From more testing to smart testing: data-guided SARS-CoV-2 testing choices, the Netherlands, May to September 2020 | Janko van Beek Zsofia Igloi Timo Boelsums Ewout Fanoy Hannelore Gotz | 2020 | |
Persistent transmission of HCV among men who have sex with men despite widespread screening and treatment with direct-acting antivirals | Viruses | Stephanie Popping Lize Cuypers Mark AA Claassen Guido E van den Berk Anja De Weggheleire | 2022/9/2 |
HIV-1 resistance against dolutegravir fluctuates rapidly alongside erratic treatment adherence: a case report | Journal of global antimicrobial resistance | Jeroen JA van Kampen Hanh Thi Pham Sunbin Yoo Ronald J Overmars Cynthia Lungu | 2022/12/1 |
Catchet-MS identifies IKZF1-targeting thalidomide analogues as novel HIV-1 latency reversal agents | Nucleic acids research | Enrico Ne Raquel Crespo Ray Izquierdo-Lara Shringar Rao Selin Koçer | 2022/6/10 |
Intention and preference for long-acting injectable PrEP among MSM in the Netherlands: a diffusion of innovation approach | medRxiv | Haoyi Wang Hanne ML Zimmermann David van de Vijver Kai J Jonas | 2022/11/11 |
